Impact of Sensitization on Waiting Time Prior to Kidney Transplantation in Germany
- PMID: 35973058
- DOI: 10.1097/TP.0000000000004238
Impact of Sensitization on Waiting Time Prior to Kidney Transplantation in Germany
Abstract
Background: Assignment of unacceptable HLA mismatches (UAMs) prevents transplantation of incompatible grafts but potentially prolongs waiting time. Whether this is true in the Eurotransplant Kidney Allocation System (ETKAS) and the Eurotransplant Senior Program in Germany is highly debated and relevant for UAM policies.
Methods: Donor pool restriction due to UAM was expressed as percent virtual panel-reactive antibodies (vPRAs). Kaplan-Meier estimates and multivariable Cox regression models were used to analyze the impact of vPRA levels on waiting time and transplant probability during a period of 2 y in all patients eligible for a kidney graft unter standard circumstances in Germany on February 1, 2019 (n = 6533). Utility of the mismatch probability score to compensate for sensitization in ETKAS was also investigated.
Results: In ETKAS, donor pool restriction resulted in significant prolongation of waiting time and reduction in transplant probability only in patients with vPRA levels above 85%. This was most evident in patients with vPRA levels above 95%, whereas patients in the acceptable mismatch program had significantly shorter waiting times and higher chances for transplantation than nonsensitized patients. In the Eurotransplant Senior Program, vPRA levels above 50% resulted in significantly longer waiting times and markedly reduced the chance for transplantation. Compensation for sensitization by the mismatch probability score was insufficient.
Conclusions: Donor pool restriction had no significant impact on waiting time in most sensitized patients. However, despite the existence of the acceptable mismatch program, the majority of highly sensitized patients is currently disadvantaged and would benefit from better compensation mechanisms.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no funding or conflicts of interest.
Comment in
-
Improving Access to Renal Transplantation for Highly Sensitized Patients.Transplantation. 2022 Dec 1;106(12):2299-2300. doi: 10.1097/TP.0000000000004239. Epub 2022 Aug 2. Transplantation. 2022. PMID: 35973049 No abstract available.
References
-
- Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969;280:735–739.
-
- Ziemann M, Suwelack B, Banas B, et al. Determination of unacceptable HLA antigen mismatches in kidney transplant recipients. HLA. 2021;100:3–17.
-
- Böhmig GA, Hidalgo LG. Single-antigen bead assays to define unacceptable antigen mismatches? Transplantation. 2018;102:894–895.
-
- Parsons RF, Locke JE, Redfield RR 3rd, et al. Kidney transplantation of highly sensitized recipients under the new kidney allocation system: a reflection from five different transplant centers across the United States. Hum Immunol. 2017;78:30–36.
-
- Zecher D, Bach C, Staudner C, et al. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen. Nephrol Dial Transplant. 2017;32:730–737.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
